selected scholarly activity
-
conferences
- Antibody idiotype plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity (ADCC) against influenza A virus. Journal of Immunology. 2016
- Fc-dependent effector functions of neutrophils induced by hemagglutinin stalk-specific antibodies. Journal of Immunology. 2016
-
journal articles
- ASK1 inhibitors are potential pan-antiviral drugs, which dampen replication of diverse viruses including SARS-CoV2. Antiviral Research. 220:105736-105736. 2023
- Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, Canada. Emerging Infectious Diseases. 29:1386-1396. 2023
- Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection. Nature Reviews Immunology. 23:381-396. 2023
- The impact of Gam-COVID-Vac, an Adv5/Adv26 COVID-19 vaccine, on the biomarkers of endothelial function, coagulation and platelet activation. PLoS ONE. 18:e0293074-e0293074. 2023
- Three on Three: Universal and High-Affinity Molecular Recognition of the Symmetric Homotrimeric Spike Protein of SARS-CoV-2 with a Symmetric Homotrimeric Aptamer. Journal of the American Chemical Society. 144:23465-23473. 2022
- Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination. Journal of Immunology. 209:1892-1905. 2022
- Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination.. Journal of Immunology. 209:1892-1905. 2022
- Sustained Delivery of a Monoclonal Antibody against SARS-CoV-2 by Microencapsulated Cells: A Proof-of-Concept Study. Pharmaceutics. 14:2042-2042. 2022
- Cigarette smoke augments CSF3 expression in neutrophils to compromise alveolar–capillary barrier function during influenza infection. European Respiratory Journal. 60:2102049-2102049. 2022
- Hemagglutinin stalk-binding antibodies enhance effectiveness of neuraminidase inhibitors against influenza via Fc-dependent effector functions. Cell Reports Medicine. 3:100718-100718. 2022
- Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study. Scientific Reports. 12:13207. 2022
- A Universal DNA Aptamer that Recognizes Spike Proteins of Diverse SARS‐CoV‐2 Variants of Concern. Chemistry - A European Journal. 28:e202200078. 2022
- A Universal DNA Aptamer that Recognizes Spike Proteins of Diverse SARS‐CoV‐2 Variants of Concern. Chemistry - A European Journal. 28:e202200524. 2022
- Front Cover: A Universal DNA Aptamer that Recognizes Spike Proteins of Diverse SARS‐CoV‐2 Variants of Concern (Chem. Eur. J. 15/2022). Chemistry - A European Journal. 28:e202200523. 2022
- Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell. 185:896-915.e19. 2022
- Inactivated and live-attenuated seasonal influenza vaccines boost broadly neutralizing antibodies in children. Cell Reports Medicine. 3:100509-100509. 2022
- Gut microbiota-based vaccination engages innate immunity to improve blood glucose control in obese mice. Molecular Metabolism. 55:101404-101404. 2022
- Antibody Responses to 3rd Dose mRNA Vaccines in Nursing Home and Assisted Living Residents 2021
- Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections. Viruses. 13:2239-2239. 2021
- High‐Affinity Dimeric Aptamers Enable the Rapid Electrochemical Detection of Wild‐Type and B.1.1.7 SARS‐CoV‐2 in Unprocessed Saliva. Angewandte Chemie International Edition. 60:24266-24274. 2021
- High‐Affinity Dimeric Aptamers Enable the Rapid Electrochemical Detection of Wild‐Type and B.1.1.7 SARS‐CoV‐2 in Unprocessed Saliva. Angewandte Chemie International Edition. 133:24468-24476. 2021
- Potentiation of long-acting β2-agonist and glucocorticoid responses in human airway epithelial cells by modulation of intracellular cAMP. Respiratory Research. 22:266. 2021
- Probe design for simultaneous, targeted capture of diverse metagenomic targets. Cell Reports Methods. 1:100069-100069. 2021
- Cigarette smoke exposure attenuates the induction of antigen-specific IgA in the murine upper respiratory tract. Mucosal Immunology. 14:1067-1076. 2021
- Antibody Responses 3-5 Months Post-Vaccination with mRNA-1273 or BNT163b2 in Nursing Home Residents 2021
- Effects of repeated vaccination and vaccine formulation on the induction of broadly neutralizing antibody responses against influenza A virus in children 2021
- Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library. Nucleic Acids Research (NAR). 49:7267-7279. 2021
- IgA potentiates NETosis in response to viral infection. Proceedings of the National Academy of Sciences of the United States of America. 118:e2101497118. 2021
- Neutrophils and Influenza: A Thin Line between Helpful and Harmful. Vaccines. 9:597-597. 2021
- A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge. Proceedings of the National Academy of Sciences of the United States of America. 118:e2025759118. 2021
- Covalent Stabilization of Antibody Recruitment Enhances Immune Recognition of Cancer Targets. Biochemistry. 60:1447-1458. 2021
- Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses. iScience. 24:102477-102477. 2021
- Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects. Viruses. 13:697-697. 2021
- Engineered Nanoparticle Applications for Recombinant Influenza Vaccines. Molecular Pharmaceutics. 18:576-592. 2021
- Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus. Journal of General Virology. 101:1251-1260. 2020
- Age-Specific Incidence of Influenza A Responds to Change in Virus Subtype Dominance. Clinical Infectious Diseases. 71:e195-e198. 2020
- Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike. Cell Reports Medicine. 1:100126-100126. 2020
- Immunological considerations for COVID-19 vaccine strategies. Nature Reviews Immunology. 20:615-632. 2020
- Bat Influenza Viruses: Making a Double Agent of MHC Class II. Trends in Microbiology. 28:703-706. 2020
- Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue. European Respiratory Journal. 56:2001123-2001123. 2020
- Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2. Emerging Infectious Diseases. 26:2054-2063. 2020
- Repeated Seasonal Influenza Vaccination: How Much Is Too Much of a Good Thing?. Journal of Infectious Diseases. 222:173-175. 2020
- Rapid Design of a Bait Capture Platform for Culture- and Amplification-Free Next-Generation Sequencing of SARS-CoV-2 2020
- Correction to: Determinants of Influenza Mortality Trends: Age-Period-Cohort Analysis of Influenza Mortality in the United States, 1959–2016. Demography. 2019
- Determinants of Influenza Mortality Trends: Age-Period-Cohort Analysis of Influenza Mortality in the United States, 1959–2016. Demography. 56:1723-1746. 2019
- Comparative Immunogenicity of the 2014–2015 Northern Hemisphere Trivalent IIV and LAIV against Influenza A Viruses in Children. Vaccines. 7:87-87. 2019
- Thermal Stabilization of Viral Vaccines in Low-Cost Sugar Films. Scientific Reports. 9:7631. 2019
- Excipient selection for thermally stable enveloped and non-enveloped viral vaccine platforms in dry powders. International Journal of Pharmaceutics. 561:66-73. 2019
- Original Antigenic Sin: How First Exposure Shapes Lifelong Anti–Influenza Virus Immune Responses. Journal of Immunology. 202:335-340. 2019
- Reporting and evaluating influenza virus surveillance data: An argument for incidence by single year of age. Vaccine. 36:6249-6252. 2018
- Reviewing the evidence for viruses as environmental risk factors for ALS: A new perspective. Cytokine. 108:173-178. 2018
- “Gnothi Seauton”: Leveraging the Host Response to Improve Influenza Virus Vaccine Efficacy. Vaccines. 6:23-23. 2018
- Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic. mBio. 9:e02091-e02017. 2018
- Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice. Nature Communications. 8:846. 2017
- Regulation of kynurenine biosynthesis during influenza virus infection. The FEBS Journal. 284:222-236. 2017
- Abnormal regulation of the antiviral response in neurological/neurodegenerative diseases. Cytokine. 88:251-258. 2016
- Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner. mBio. 7:e01624-e01616. 2016
- Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus. Proceedings of the National Academy of Sciences of the United States of America. 113:11931-11936. 2016
- Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact. Proceedings of the National Academy of Sciences of the United States of America. 113:E5944-E5951. 2016
- Autoimmune VariantPTPN22C1858T Is Associated With Impaired Responses to Influenza Vaccination. Journal of Infectious Diseases. 214:248-257. 2016
- Hemagglutinin Stalk Immunity Reduces Influenza Virus Replication and Transmission in Ferrets. Journal of Virology. 90:3268-3273. 2016
- CARMA3 Is a Host Factor Regulating the Balance of Inflammatory and Antiviral Responses against Viral Infection. Cell Reports. 14:2389-2401. 2016
- Measuring the neutralization potency of influenza A virus hemagglutinin stalk/stem-binding antibodies in polyclonal preparations by microneutralization assay. ImmunoMethods. 90:95-100. 2015
- Senataxin suppresses the antiviral transcriptional response and controls viral biogenesis. Nature Immunology. 16:485-494. 2015
- Broadly Neutralizing Anti-Influenza Virus Antibodies: Enhancement of Neutralizing Potency in Polyclonal Mixtures and IgA Backbones. Journal of Virology. 89:3610-3618. 2015
- Is Antigenic Sin Always “Original?” Re-examining the Evidence Regarding Circulation of a Human H1 Influenza Virus Immediately Prior to the 1918 Spanish Flu. PLoS Pathogens. 11:e1004615-e1004615. 2015
- Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans. Proceedings of the National Academy of Sciences of the United States of America. 111:13133-13138. 2014
- Peering into the Crystal Ball: Influenza Pandemics and Vaccine Efficacy. Cell. 157:294-299. 2014
- Assessment of Influenza Virus Hemagglutinin Stalk-Based Immunity in Ferrets. Journal of Virology. 88:3432-3442. 2014
- Neutralizing Antibodies Against Previously Encountered Influenza Virus Strains Increase over Time: A Longitudinal Analysis. Science Translational Medicine. 5:198ra107. 2013
- Serum- and Glucocorticoid-Regulated Kinase 1 Is Required for Nuclear Export of the Ribonucleoprotein of Influenza A Virus. Journal of Virology. 87:6020-6026. 2013
- 1976 and 2009 H1N1 Influenza Virus Vaccines Boost Anti-Hemagglutinin Stalk Antibodies in Humans. Journal of Infectious Diseases. 207:98-105. 2013
- Age-Specific Mortality During the 1918 Influenza Pandemic: Unravelling the Mystery of High Young Adult Mortality. PLoS ONE. 8:e69586-e69586. 2013
- Characterization of the 55-Residue Protein Encoded by the 9S E1A mRNA of Species C Adenovirus. Journal of Virology. 86:4222-4233. 2012
- Adenovirus E1A Directly Targets the E2F/DP-1 Complex. Journal of Virology. 85:8841-8851. 2011
- An unhealthy relationship: viral manipulation of the nuclear receptor superfamily. Future Microbiology. 6:999-1019. 2011
- RASCAL Is a New Human Cytomegalovirus-Encoded Protein That Localizes to the Nuclear Lamina and in Cytoplasmic Vesicles at Late Times Postinfection. Journal of Virology. 84:6483-6496. 2010
- Onset of Human Cytomegalovirus Replication in Fibroblasts Requires the Presence of an Intact Vimentin Cytoskeleton. Journal of Virology. 83:7015-7028. 2009
- Human cytomegalovirus US9 protein contains an N-terminal signal sequence and a C-terminal mitochondrial localization domain, and does not alter cellular sensitivity to apoptosis. Journal of General Virology. 90:1172-1182. 2009
-
preprints